{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:01:15Z","timestamp":1791496875029,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1124\/jpet.108.144311","type":"journal-article","created":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T02:38:15Z","timestamp":1228444695000},"page":"758-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Aerosolized Phosphoinositide 3-Kinase \u03b3\/\u03b4 Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease"],"prefix":"10.1016","volume":"328","author":[{"given":"John","family":"Doukas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Eide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Stebbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Racanelli-Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Dellamary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Dneprovskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Soll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Wrasidlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette M.","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Cheresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.144311_bib1","doi-asserted-by":"crossref","unstructured":"Adcock IM, Caramori G, and Ito K (2006a) New insights into the molecular mechanisms of corticosteroids actions. Curr Drug Targets 7: 649-660.","DOI":"10.2174\/138945006777435344"},{"key":"10.1124\/jpet.108.144311_bib2","doi-asserted-by":"crossref","unstructured":"Adcock IM, Chung KF, Caramori G, and Ito K (2006b) Kinase inhibitors and airway inflammation. Eur J Pharmacol 533: 118-132.","DOI":"10.1016\/j.ejphar.2005.12.054"},{"key":"10.1124\/jpet.108.144311_bib3","doi-asserted-by":"crossref","unstructured":"Adcock IM, Ford PA, Bhavsar P, Ahmad T, and Chung KF (2008) Steroid resistance in asthma: mechanisms and treatment options. Curr Allergy Asthma Rep 8: 171-178.","DOI":"10.1007\/s11882-008-0028-4"},{"key":"10.1124\/jpet.108.144311_bib4","doi-asserted-by":"crossref","unstructured":"Adcock IM and Ito K (2004) Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue? Curr Opin Pharmacol 4: 257-262.","DOI":"10.1016\/j.coph.2004.02.001"},{"key":"10.1124\/jpet.108.144311_bib5","doi-asserted-by":"crossref","unstructured":"Al-Alwan MM, Okkenhaug K, Vanhaesebroeck B, Hayflick JS, and Marshall AJ (2007) Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation. J Immunol 178: 2328-2335.","DOI":"10.4049\/jimmunol.178.4.2328"},{"key":"10.1124\/jpet.108.144311_bib6","doi-asserted-by":"crossref","unstructured":"Ali K, Bilancio A, Thomas M, Pearce W, Gilfillan AM, Tkaczyk C, Kuehn N, Gray A, Giddings J, Peskett E, et al. (2004) Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 431: 1007-1011.","DOI":"10.1038\/nature02991"},{"key":"10.1124\/jpet.108.144311_bib7","doi-asserted-by":"crossref","unstructured":"Ali K, Camps M, Pearce WP, Ji H, R\u00fcckle T, Kuehn N, Pasquali C, Chabert C, Rommel C, and Vanhaesebroeck B (2008) Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo. J Immunol 180: 2538-2544.","DOI":"10.4049\/jimmunol.180.4.2538"},{"key":"10.1124\/jpet.108.144311_bib8","doi-asserted-by":"crossref","unstructured":"Bailey WC and Tashkin DP (2007) Pharmacologic therapy: novel approaches for chronic obstructive pulmonary disease. Proc Am Thorac Soc 4: 543-548.","DOI":"10.1513\/pats.200701-017FM"},{"key":"10.1124\/jpet.108.144311_bib9","doi-asserted-by":"crossref","unstructured":"Baraldo S, Lokar Oliani K, Turato G, Zuin R, and Saetta M (2007) The role of lymphocytes in the pathogenesis of asthma and COPD. Curr Med Chem 14: 2250-2256.","DOI":"10.2174\/092986707781696573"},{"key":"10.1124\/jpet.108.144311_bib10","doi-asserted-by":"crossref","unstructured":"Barber DF, Bartolom\u00e9 A, Hernandez C, Flores JM, Redondo C, Fernandez-Arias C, Camps M, R\u00fcckle T, Schwarz MK, Rodr\u00edguez S, et al. (2005) PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 11: 933-935.","DOI":"10.1038\/nm1291"},{"key":"10.1124\/jpet.108.144311_bib11","doi-asserted-by":"crossref","unstructured":"Barnes PJ (2004) New drugs for asthma. Nat Rev Drug Discov 3: 831-844.","DOI":"10.1038\/nrd1524"},{"key":"10.1124\/jpet.108.144311_bib12","doi-asserted-by":"crossref","unstructured":"Barnes PJ (2008) Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8: 183-192.","DOI":"10.1038\/nri2254"},{"key":"10.1124\/jpet.108.144311_bib13","doi-asserted-by":"crossref","unstructured":"Barnes PJ, Ito K, and Adcock IM (2004) Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 363: 731-733.","DOI":"10.1016\/S0140-6736(04)15650-X"},{"key":"10.1124\/jpet.108.144311_bib14","doi-asserted-by":"crossref","unstructured":"Bloemen K, Verstraelen S, Van Den Heuvel R, Witters H, Nelissen I, and Schoeters G (2007) The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett 113: 6-18.","DOI":"10.1016\/j.imlet.2007.07.010"},{"key":"10.1124\/jpet.108.144311_bib15","doi-asserted-by":"crossref","unstructured":"Camps M, R\u00fcckle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Fran\u00e7on B, et al. (2005) Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11: 936-943.","DOI":"10.1038\/nm1284"},{"key":"10.1124\/jpet.108.144311_bib16","doi-asserted-by":"crossref","unstructured":"Doherty DE (2004) The pathophysiology of airway dysfunction. Am J Med 117 (Suppl 12A): 11S-23S.","DOI":"10.1016\/j.amjmed.2004.10.017"},{"key":"10.1124\/jpet.108.144311_bib17","doi-asserted-by":"crossref","unstructured":"Doukas J, Wrasidlo W, Noronha G, Dneprovskaia E, Fine R, Weis S, Hood J, Demaria A, Soll R, and Cheresh D (2006) Phosphoinositide 3-kinase gamma\/delta inhibition limits infarct size after myocardial ischemia\/reperfusion injury. Proc Natl Acad Sci U S A 103: 19866-19871.","DOI":"10.1073\/pnas.0606956103"},{"key":"10.1124\/jpet.108.144311_bib18","doi-asserted-by":"crossref","unstructured":"Finan PM and Thomas MJ (2004) PI 3-kinase inhibition: a therapeutic target for respiratory disease. Biochem Soc Trans 32: 378-382.","DOI":"10.1042\/bst0320378"},{"key":"10.1124\/jpet.108.144311_bib19","doi-asserted-by":"crossref","unstructured":"Goncharova EA, Ammit AJ, Irani C, Carroll RG, Eszterhas AJ, Panettieri RA, and Krymskaya VP (2002) PI3K is required for proliferation and migration of human pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 283: L354-L363.","DOI":"10.1152\/ajplung.00010.2002"},{"key":"10.1124\/jpet.108.144311_bib20","doi-asserted-by":"crossref","unstructured":"Hannigan M, Zhan L, Li Z, Ai Y, Wu D, and Huang CK (2002) Neutrophils lacking phosphoinositide 3-kinase gamma show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc Natl Acad Sci U S A 99: 3603-3608.","DOI":"10.1073\/pnas.052010699"},{"key":"10.1124\/jpet.108.144311_bib21","doi-asserted-by":"crossref","unstructured":"Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, and Wymann MP (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287: 1049-1053.","DOI":"10.1126\/science.287.5455.1049"},{"key":"10.1124\/jpet.108.144311_bib22","unstructured":"Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC. Ito K, Caramori G, and Adcock IM (2007) Therapeutic potential of phosphatidylinositol 3-kinase inhibitors in inflammatory respiratory disease. J Pharmacol Exp Ther 321: 1-8."},{"key":"10.1124\/jpet.108.144311_bib23","doi-asserted-by":"crossref","unstructured":"Ji H, Rintelen F, Waltzinger C, Bertschy Meier D, Bilancio A, Pearce W, Hirsch E, Wymann MP, R\u00fcckle T, Camps M, et al. (2007) Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation. Blood 110: 2940-2947.","DOI":"10.1182\/blood-2007-04-086751"},{"key":"10.1124\/jpet.108.144311_bib24","doi-asserted-by":"crossref","unstructured":"Jou ST, Carpino N, Takahashi Y, Piekorz R, Chao JR, Carpino N, Wang D, and Ihle JN (2002) Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol 22: 8580-8591.","DOI":"10.1128\/MCB.22.24.8580-8591.2002"},{"key":"10.1124\/jpet.108.144311_bib25","doi-asserted-by":"crossref","unstructured":"Krymskaya VP (2007) Targeting the phosphatidylinositol 3-kinase pathway in airway smooth muscle: rationale and promise. BioDrugs 21: 85-95.","DOI":"10.2165\/00063030-200721020-00003"},{"key":"10.1124\/jpet.108.144311_bib26","doi-asserted-by":"crossref","unstructured":"Krymskaya VP, Goncharova EA, Ammit AJ, Lim PN, Goncharov DA, Eszterhas A, and Panettieri RA Jr (2005) Src is necessary and sufficient for human airway smooth muscle cell proliferation and migration. FASEB J 19: 428-430.","DOI":"10.1096\/fj.04-2869fje"},{"key":"10.1124\/jpet.108.144311_bib27","doi-asserted-by":"crossref","unstructured":"Kwak YG, Song CH, Yi HK, Hwang PH, Kim JS, Lee KS, and Lee YC (2003) Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest 111: 1083-1092.","DOI":"10.1172\/JCI200316440"},{"key":"10.1124\/jpet.108.144311_bib28","doi-asserted-by":"crossref","unstructured":"Labiris NR and Dolovich MB (2003) Pulmonary drug delivery: I. Physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 56: 588-599.","DOI":"10.1046\/j.1365-2125.2003.01892.x"},{"key":"10.1124\/jpet.108.144311_bib29","doi-asserted-by":"crossref","unstructured":"Laffargue M, Calvez R, Finan P, Trifilieff A, Barbier M, Altruda F, Hirsch E, and Wymann MP (2002) Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity 16: 441-451.","DOI":"10.1016\/S1074-7613(02)00282-0"},{"key":"10.1124\/jpet.108.144311_bib30","doi-asserted-by":"crossref","unstructured":"Lee KS, Lee HK, Hayflick JS, Lee YC, and Puri KD (2006) Inhibition of phospho-inositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB J 20: 455-465.","DOI":"10.1096\/fj.05-5045com"},{"key":"10.1124\/jpet.108.144311_bib31","doi-asserted-by":"crossref","unstructured":"Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, et al. (2003) Future directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute Working Group. Am J Respir Crit Care Med 167: 1027-1035.","DOI":"10.1164\/rccm.200208-966WS"},{"key":"10.1124\/jpet.108.144311_bib32","doi-asserted-by":"crossref","unstructured":"Matthews JG, Ito K, Barnes PJ, and Adcock IM (2004) Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol 113: 1100-1108.","DOI":"10.1016\/j.jaci.2004.03.018"},{"key":"10.1124\/jpet.108.144311_bib33","doi-asserted-by":"crossref","unstructured":"Nashed BF, Zhang T, Al-Alwan M, Srinivasan G, Halayko AJ, Okkenhaug K, Vanhaesebroeck B, Hayglass KT, and Marshall AJ (2007) Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation. Eur J Immunol 37: 416-424.","DOI":"10.1002\/eji.200636401"},{"key":"10.1124\/jpet.108.144311_bib34","doi-asserted-by":"crossref","unstructured":"Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield MD, et al. (2002) Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297: 1031-1034.","DOI":"10.1126\/science.1073560"},{"key":"10.1124\/jpet.108.144311_bib35","doi-asserted-by":"crossref","unstructured":"Palanki MS, Dneprovskaia E, Doukas J, Fine RM, Hood J, Kang X, Lohse D, Martin M, Noronha G, Soll RM, et al. (2007) Discovery of 3,3\u2032-(2,4-diaminopteridine-6,7-diyl)diphenol as an isozyme-selective inhibitor of PI3K for the treatment of ischemia reperfusion injury associated with myocardial infarction. J Med Chem 50: 4279-4294.","DOI":"10.1021\/jm051056c"},{"key":"10.1124\/jpet.108.144311_bib36","doi-asserted-by":"crossref","unstructured":"Rommel C, Camps M, and Ji H (2007) PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol 7: 191-201.","DOI":"10.1038\/nri2036"},{"key":"10.1124\/jpet.108.144311_bib37","doi-asserted-by":"crossref","unstructured":"Sadhu C, Dick K, Tino WT, and Staunton DE (2003) Selective role of PI3K delta in neutrophil inflammatory responses. Biochem Biophys Res Commun 308: 764-769.","DOI":"10.1016\/S0006-291X(03)01480-3"},{"key":"10.1124\/jpet.108.144311_bib38","doi-asserted-by":"crossref","unstructured":"Thomas MJ, Smith A, Head DH, Milne L, Nicholls A, Pearce W, Vanhaesebroeck B, Wymann MP, Hirsch E, Trifilieff A, et al. (2005) Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. Eur J Immunol 35: 1283-1291.","DOI":"10.1002\/eji.200425634"},{"key":"10.1124\/jpet.108.144311_bib39","doi-asserted-by":"crossref","unstructured":"Tigani B, Hannon JP, Mazzoni L, and Fozard JR (2001) Effects of wortmannin on airways inflammation induced by allergen in actively sensitised Brown Norway rats. Eur J Pharmacol 433: 217-223.","DOI":"10.1016\/S0014-2999(01)01515-1"},{"key":"10.1124\/jpet.108.144311_bib40","doi-asserted-by":"crossref","unstructured":"Vanhaesebroeck B, Ali K, Bilancio A, Geering B, and Foukas LC (2005) Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem Sci 30: 194-204.","DOI":"10.1016\/j.tibs.2005.02.008"},{"key":"10.1124\/jpet.108.144311_bib41","doi-asserted-by":"crossref","unstructured":"Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, and Waterfield MD (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70: 535-602.","DOI":"10.1146\/annurev.biochem.70.1.535"},{"key":"10.1124\/jpet.108.144311_bib42","doi-asserted-by":"crossref","unstructured":"Welte T and Groneberg DA (2006) Asthma and COPD. Exp Toxicol Pathol 57 (Suppl 2): 35-40.","DOI":"10.1016\/j.etp.2006.02.004"},{"key":"10.1124\/jpet.108.144311_bib43","doi-asserted-by":"crossref","unstructured":"Yum HK, Arcaroli J, Kupfner J, Shenkar R, Penninger JM, Sasaki T, Yang KY, Park JS, and Abraham E (2001) Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol 167: 6601-6608.","DOI":"10.4049\/jimmunol.167.11.6601"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524348281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524348281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.144311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:52:07Z","timestamp":1740005527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524348281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0022356524348281"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.144311","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aerosolized Phosphoinositide 3-Kinase \u03b3\/\u03b4 Inhibitor TG100-115 [3-[2,4-Diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a Therapeutic Candidate for Asthma and Chronic Obstructive Pulmonary Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.144311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}